Position:Senior Research Statistician
Telephone:01865 857253
Email:ruth.coleman@dtu.ox.ac.uk
Ruth is a Senior Research Statistician at the Diabetes Trials Unit.
Her ongoing projects include the expansion of the UKPDS Risk Engine to include estimates of both cardiovascular and microvascular disease risk, and modelling life expectancy in type 2 diabetes.
She is currently the statistical lead for the ACE study.
Manuscript
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Philip M Clarke et al.
Diabetes Care 2025
Manuscript
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Ruth L Coleman et al.
Cardiovasc Diabetol. 2025;24:347
Manuscript
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis
Erenesto Maddaloni et al.
Diabetes Res Clin Pract. 2025;223:112125
Manuscript
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply
Amanda I Adler et al.
Lancet 2025;405:29
Manuscript
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)
Beryl Lin et al.
Lancet Diabetes Endocrinol. 2024;12:904-914
Manuscript
Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial
Abderrahim Oulhaj et al.
Diabetes Obes Metab. 2024;26:4602-4612